Vanda Pharmaceuticals Inc (VNDA)
5.02
+0.13
(+2.66%)
USD |
NASDAQ |
Nov 07, 16:00
5.015
0.00 (0.00%)
After-Hours: 20:00
Vanda Pharmaceuticals Revenue (Annual): 192.64M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 192.64M |
| December 31, 2022 | 254.38M |
| December 31, 2021 | 268.68M |
| December 31, 2020 | 248.17M |
| December 31, 2019 | 227.19M |
| December 31, 2018 | 193.12M |
| December 31, 2017 | 165.08M |
| December 31, 2016 | 146.02M |
| December 31, 2015 | 109.92M |
| December 31, 2014 | 50.16M |
| Date | Value |
|---|---|
| December 31, 2013 | 33.88M |
| December 31, 2012 | 32.73M |
| December 31, 2011 | 31.27M |
| December 31, 2010 | 35.22M |
| December 31, 2009 | 4.548M |
| December 31, 2008 | |
| December 31, 2007 | |
| December 31, 2006 | |
| December 31, 2005 | |
| December 31, 2004 | 0.034M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
192.64M
Minimum
2023
268.68M
Maximum
2021
238.21M
Average
248.17M
Median
2020
Revenue (Annual) Benchmarks
| Zevra Therapeutics Inc | 27.46M |
| Edgewise Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 14.73M |
| Palatin Technologies Inc | 4.490M |
| iBio Inc | 0.225M |